tests, diurnal cortisol levels and basal adrenocorticotropic hormone levels were assessed to exclude hypothyroidism and hypercortisolism. All participants were at puberty, so they were referred to as "adolescents". The pubertal stages were determined according to Marshall and Tanner [18] . The study was approved by the Scientific Ethics Committee of Celal Bayar University, Medical School. An informed written consent was obtained from the parents of all children who underwent OGTT and other biochemical investigations without any incentive or compensation.
Anthropometric measurements
Weight was measured to the nearest 0.5 kg using a balance beam scale and height was measured to the nearest 0.1 cm with a manual height board. The calculated Body Mass Index (BMI; kg/m 2 ) was used as an index of relative weight. BMI standard deviation scores (SDS) were calculated and BMI percentiles were evaluated for age and gender according to national standarts. The SDS represented the number of standard deviations above or below the mean value of the considered population which is based on standardized tables for children and adolescents.
Oral glucose tolerance test (OGTT)
A standard OGTT at 8:00 was performed in all obese adolescents to establish their glucose tolerance. After the overnight fasting, an antecubital intravenous catheter was inserted for blood sampling and its patency was maintained by slow infusion of normal saline. A flavored glucose solution at a dose of 1.75g/kg body weight (up to a maximum of 75 g) was given orally and blood samples were obtained for glucose and insulin measurements every 30 minutes for 120 minutes.
Definitions
Obesity was defined as having a percentile of BMI ≥ 95 th for age and sex [19] . Based on OGTT results, 80 participants were divided into three groups. First and second groups were defined according to International Federation of Diabetes (IDF) criteria. The first group (normal glucose tolerance, NGT) was defined as having fasting glucose levels < 100 mg/dL and 2-hour glucose levels < 140 mg/dL. The second group (IGT) was defined as having fasting glucose levels < 100 mg/ dL and 2-hour glucose levels between 140-199 mg/ dL [20, 21] . Finally, the third group (blood glucose (BG)>140 mg/dL at 30 minutes) was recruited from 9]. It is postulated that increased macrophage accumulation in white adipose tissue, particularly in the visceral depots, promotes synthesis of inflammatory mediators [10] . In the literature, there are numerous studies demonstrating increased C-reactive protein (CRP), tumor necrosis factor alpha (TNF-α) and interluekin-6 (IL-6) levels in obese children [11] . The role of inflammation and immune activation in atherogenesis is well established [12] . Elevated neopterin levels produced by human monocyte-derived macrophages and dendritic cells, provide information about patients at risk for myocardial infarction [13, 14] . Lipoproteinassociated phospholipase A 2 (Lp-PLA 2 ) is considered to be a novel inflammatory marker. Moreover, in adults, elevated Lp-PLA 2 is accepted as a cardiovascular risk marker independent of traditional risk factors such as increased low density lipoprotein cholesterol (LDL-C) and CRP [15] . However, studies in obese children regarding neopterin and Lp-PLA 2 levels are few in numbers [16, 17] . Persistent inflammation in obese children may increase the risks of metabolic and cardiovascular events later in life [11] .
In our clinical practice, we have observed that some obese adolescents had glucose levels >140 mg/dL at 30 minutes during an OGTT. The aim of this study was to evaluate clinical significance of elevated glucose levels at 30 minutes during OGTT in obese adolescents. Therefore, we compared lipid profiles, insulin resistance, and systemic inflammatory mediators which are atherosclerotic indicators, of these adolescents with those of obese adolescents with normal and impaired glucose tolerance.
subjects and Methods

Study design and methods
Eighty obese adolescents (48 girls and 32 boys; mean age 13.61 ± 2.07 years; mean body mass index (BMI) 30.24 ± 5.70 kg/m 2 ) at puberty were included in this study. All adolescents were recruited from the Pediatric Endocrinology and Metabolism outpatient unit of the hospital.
After the overnight fasting, venous blood samples were drawn to assess glucose, insulin, glycated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), high-density lipoprotein-cholesterol (HDL-C), apolipoprotein AI (Apo A), apolipoprotein B100 (Apo B), fibrinogen, CRP, IL-6, neopterin levels and Lp-PLA 2 activities. In all subjects, thyroid function
Statistical analysis
Statistical Package for Social Sciences for Windows statistical software version 16.0 was used. Data distribution was analyzed by using the KolmogorovSmirnov test. Anthropometric and biochemical parameters were compared by Kruskal-Wallis analysis among the three groups. Mann-Whitney-U test was used to compare the two groups. Pearson's or Spearman's correlation coefficients were used to quantify the univariate associations among variables. Two logistic regression models were used to identify predictors of high glucose levels measured at 30 min. during OGTT. First model was calculated for NGT and groups which had glucose levels >140 mg/dL at 30 min. The second one was calculated for NGT and IGT groups. IL-6, neopterin, Lp-PLA 2 , CRP and fibrinogen were independent variables for both models. Data were expressed as mean±SD. Level of significance for differences was considered at p < 0.05.
Results
Mean age of obese adolescents was 13.61 ± 2.07 years. Of these patients 40.0% (n=32) were male, 60.0% (n=48) were female. The female to male ratios in NGT, IGT and the group which had increased glucose levels at 30 min. were 15:10, 17:9 and 16:13, respectively. There was no significant difference in age between three groups (p=0.228) ( Table 1) .
Glucose and insulin levels at fasting, 30 
Biochemical analysis
All of biochemical analyses were performed on the sample collection day, except for IL-6, neopterin and Lp-PLA 2 measurements, for which fasting serum samples were stored at -80 °C until the time of analysis. Glucose levels were measured with hexokinase (Beckman Coulter, USA) and insulin levels were measured with immunchemiluminescence (Siemens, USA) methods on autoanalyzers. The fasting values of HbA1c, TC, TG, HDL-C, Apo A, Apo B and CRP were determined by commercially available kits (Beckman Coulter, USA). Plasma fibrinogen levels were measured by Clauss method on a coagulometer (Beckman Coulter, USA). LDL-C was calculated by the Friedewald equation [25] .
The fasting serum concentrations of IL-6, neopterin and Lp-PLA 2 were determined by use of ELISA (DIA Source, Belgium, DRG Instruments GmbH, Germany and dia Dexus, Inc. USA, respectively). The lowest detection limits were approximately 2 pg/mL for IL-6, 0.2 ng/mL for neopterin, and 0.34 ng/mL for Lp-PLA 2 . The same independent variables were included in the second logistic regression model for NGT and IGT groups. There was no statistically significant relationship between the variables (Table 4) . compared (Table 3) , obese adolescents with elevated glucose level at 30 min. displayed significantly higher neopterin and Lp-PLA 2 levels in comparison with those in NGT and IGT groups (p=0.004 and p= 0.042 with p=0.002 and p= 0.021, respectively), whereas IL-6 levels in this group was significantly higher only than those in NGT (p=0.003).
In bivariate analysis, BMI positively correlated with fasting insulin levels and HOMA-IR in the whole group (r=0.646 and r=0.631, respectively) (p<0.05). Similarly, a positive correlation between BMI and fasting insulin levels were obtained within groups (r=0.532, r=0.517, r=0.651; p<0.05). There was a positive correlation between Lp-PLA 2 levels and BMI SDS only in obese adolescents with elevated glucose levels at 30 min (r=0.461; p<0.05).
BMI, IL-6, neopterin, fibrinogen, CRP, and Lp-PLA 2 lar diseases [27, 28] . In this study, we demonstrated marked increases of IL-6, neopterin and Lp-PLA 2 in obese adolescents with elevated glucose level at 30 min compared to NGT and IGT groups. Similarly, in logistic regression models, we showed that IL-6, neopterin, and Lp-PLA 2 levels were independent predictors for high blood glucose levels at 30 minutes in OGTT. Our results have emphasized significance of high blood glucose levels measured at 30 min. During OGTT. Yeste et al. demonstrated that IL-6 levels in glucose-intolerant obese patients were significantly higher compared to normotolerant obese control subjects [29] . Inconsistent with Yeste [29] , we found that IL-6 and other inflammatory mediators did not differ between obese subjects with NGT and IGT. These results suggest that in obesity, higher blood glucose levels at 30 minutes result in more increased inflammatory response than IGT. Bardini et al. have reported that elevated first hour plasma glucose in subjects with NGT and pre-diabetes were related with subclinical inflammation, high lipid ratios, and insulin resistance in adults. Therefore, they proposed that this finding as a new "marker" for cardiovascular risk [30] . There is no study regarding the relationship between inflammatory mediators and glucose levels>140 mg/dL at 30 min during on OGTT in the literature.
Discussion
Similar to reports from all over the world, the prevalence of obesity is increasing in our country. In our previous study, we have reported the obesity frequency as 16.8% among high school adolescents [26] . Obesity is associated with alterations in glucose metabolism that may be present in adolescents. OGTT is a screening tool necessary to assess the risk of alterations in glucose metabolism in obese adolescents [27, 28] . In our clinic, all adolescents with obesity, defined as having a BMI equal to or greater than the age-and sexspecific cutpoints, undergo 2-h OGTT. During evaluations of OGTT results according to IDF criteria [20] , we have observed a different pattern neither NGT nor IGT. Some obese adolescents had glucose levels >140 mg/dL in samples drawn at 30 minutes. This is the first study which has investigated clinical significance of glucose level>140 mg/dL at 30 min during an OGTT by comparing lipid profiles, HOMA-IR and systemic inflammatory mediators levels between obese adolescents with NGT, IGT and elevated glucose levels at 30 min.
Inflammation is one of the strongest mechanisms linking increased adiposity and the development of insulin resistance, type 2 diabetes and cardiovascu- omental and subcutaneous adipose tissues [37] . WC, as anthropometric index was a significant marker of total and abdominal fat independently from BMI percentiles in adolescents [38] . Although subjects with elevated glucose levels at 30 min. had higher IL-6 levels which have been indicated the increased fat than in those with NGT groups, WC did not differ significantly among three groups. In our study, lipoprotein levels did not differ between three groups. It should be emphasized that obese adolescents with IGT have marked peripheral insulin resistance, which is mainly at the level of muscle [39] . In previous study, we didn't obtained similar results. In this study, insulin resistance was assessed by both HOMA-IR and ISI MATSUDA . Weiss et al. demonstrated elevations in fasting insulin levels, and insulin resistance was increased as the obesity stage was increased [40] . Consistent with Weiss et al., we found positive correlations between fasting insulin level and HOMA-IR and BMI in all obese adolescents.
In conclusion, obese adolescents with elevated glucose level at 30 min. during OGTT, have higher systemic inflammatory mediator levels even than in those with IGT. In these subjects, insulin increment is insufficient to decrease blood glucose concentrations at 30 th minutes after glucose loading. This finding may be classified as a new alteration of glucose metabolism in obese adolescents, a different status other than IFG and IGT. We have thought that this alteration must be taken into consideration while evaluating OGTT results of obese adolescents. Additionally, in obese children, neopterin and Lp-PLA 2 may be accepted as new markers of systemic inflammation. Further longitudinal studies which will enlighten whether this condition is a transient phenomenon in the same cohort, are required to confirm our results.
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Indeed, subjects with elevated glucose levels at 30 min have normal glucose tolerance. However, they have more risk for inflammation than subjects with IGT according to our results. Even normally handled load of glucose could lead to pro-inflammatory oxidative stress. Insulin secreted to decrease glucose level has an anti-inflammatory effect [31] . Insulin exhibits proinflammatory effects in the long-term period [32] . Defects in early phase insulin secretion may also be related to increased inflammatory mediators. However, our subjects in three groups had high insulin levels at 30 min in OGTT as well, but no significant difference was detected in early phase insulin levels among the three groups. In addition, the insulinogenic index defined as the ratio of the increment in insulin concentration to the increment in glucose concentration (∆I/∆G) was the lowest in subjects with elevated glucose levels at 30 min. In other words, increment of insulin concentration to the increment of glucose concentration was insufficient in these subjects. Obese subjects with NGT had both the highest increment of insulin concentration and the lowest systemic inflammatory mediator levels when compared to other two groups. These results suggest that proinflammatory effects of glucose have been more prominent, because it seems like insulin increment has failed to decrease glucose concentrations in obese with BG>140 mg/dL at 30 min.
Despite the large number of studies assessing inflammatory mediators in obese children and adolescents in the literature [8, 9, 29, 33, 34] , there are only few studies regarding inflammatory mediators in obese adolescents with IGT [29, 35] . We have studied five markers of inflammation in obese adolescents. Among them, IL-6, neopterin and Lp-PLA 2 are significantly increased in obese adolescents with the elevated glucose level at 30 min. There is only one study regarding neopterin in obesity, in which lower neopterin concentrations have been reported in juvenile obese patients [17] . We did not compare obese patients to healthy subjects. Despite lack of knowledge of effects of Lp-PLA 2 in obesity, a large number of prospective studies conducted in initially healthy subjects and on patients with manifest atherosclerosis have documented, Lp-PLA 2 activity was associated with increased cardiovascular risk, suggesting a proatherogenic activity [16, 36] . We found elevated Lp-PLA 2 levels and a positive relationship with the degree of obesity in participants with the elevated glucose levels at 30 min. IL-6 is produced by
